Published in Virology on May 06, 2010
Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort. Viruses (2011) 0.87
The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome. Vet Immunol Immunopathol (2011) 0.75
Initial sequence and comparative analysis of the cat genome. Genome Res (2007) 4.67
Nucleotide sequences of a feline leukemia virus subgroup A envelope gene and long terminal repeat and evidence for the recombinational origin of subgroup B viruses. J Virol (1986) 2.34
Selection forces and constraints on retroviral sequence variation. Science (2001) 2.17
Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83
Leukemogenesis by Moloney murine leukemia virus: a multistep process. Trends Microbiol (1997) 1.66
Isolation of a feline leukaemia provirus containing the oncogene myc from a feline lymphosarcoma. Nature (1984) 1.45
Defective endogenous proviruses are expressed in feline lymphoid cells: evidence for a role in natural resistance to subgroup B feline leukemia viruses. J Virol (1994) 1.34
Feline leukaemia virus: generation of pathogenic and oncogenic variants. Curr Top Microbiol Immunol (1991) 1.32
Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J Virol (1993) 1.28
Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus. J Virol (1989) 1.22
Endogenous env elements: partners in generation of pathogenic feline leukemia viruses. Virus Genes (1995) 1.20
flvi-1, a common integration domain of feline leukemia virus in naturally occurring lymphomas of a particular type. J Virol (1990) 1.15
Biologically selected recombinants between feline leukemia virus (FeLV) subgroup A and an endogenous FeLV element. Virology (1992) 1.12
Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses. J Virol (1991) 1.10
Genomically intact endogenous feline leukemia viruses of recent origin. J Virol (2004) 1.08
Genetic determinants of feline leukemia virus-induced lymphoid tumors: patterns of proviral insertion and gene rearrangement. J Virol (1994) 1.07
Feline leukemia virus: pathogenesis of neoplastic disease. Cancer Invest (1992) 1.06
Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol (2005) 1.04
Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. J Gen Virol (2004) 0.98
Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol (2005) 0.98
Pathogenicity of feline leukemia virus is commonly associated with variant viruses. Leukemia (1992) 0.92
Genetic characterization of feline leukemia virus from Florida panthers. Emerg Infect Dis (2008) 0.92
Copy number polymorphism of endogenous feline leukemia virus-like sequences. Mol Cell Probes (2007) 0.90
Naturally occurring feline leukemia virus subgroup A and B infections in urban domestic cats. J Gen Virol (2008) 0.89
Tumorigenic potential of a myc-containing strain of feline leukemia virus in vivo in domestic cats. J Virol (1988) 0.87
Insertional polymorphisms of endogenous feline leukemia viruses. J Virol (2005) 0.87
In vivo evolution and selection of recombinant feline leukemia virus species. Virus Res (1998) 0.85
Advances in understanding molecular determinants in FeLV pathology. Vet Immunol Immunopathol (2008) 0.83
Subtle mutational changes in the SU protein of a natural feline leukemia virus subgroup A isolate alter disease spectrum. J Virol (2005) 1.04
Feline leukaemia virus LTR variation and disease association in a geographical and temporal cluster. J Gen Virol (2004) 0.98
Unique long terminal repeat and surface glycoprotein gene sequences of feline leukemia virus as determinants of disease outcome. J Virol (2005) 0.98
Disruption of hematopoiesis and thymopoiesis in the early premalignant stages of infection with SL3-3 murine leukemia virus. J Virol (2002) 0.96
Regulation of FeLV-945 by c-Myb binding and CBP recruitment to the LTR. Virol J (2004) 0.90
Viral determinants of FeLV infection and pathogenesis: lessons learned from analysis of a natural cohort. Viruses (2011) 0.87
Growth regulation of simian and human AIDS-related non-Hodgkin's lymphoma cell lines by TGF-beta1 and IL-6. BMC Cancer (2007) 0.83
Matrix attachment regions as targets for retroviral integration. Virol J (2005) 0.82
Distinctive receptor binding properties of the surface glycoprotein of a natural feline leukemia virus isolate with unusual disease spectrum. Retrovirology (2011) 0.82
Apoptotic induction in B-cell acute lymphoblastic leukemia cell lines treated with a protein kinase Cβ inhibitor. Leuk Lymphoma (2011) 0.79
Diminished potential for B-lymphoid differentiation after murine leukemia virus infection in vivo and in EML hematopoietic progenitor cells. J Virol (2007) 0.77
Protein kinase C-beta inhibition induces apoptosis and inhibits cell cycle progression in acquired immunodeficiency syndrome-related non-hodgkin lymphoma cells. J Investig Med (2012) 0.77
Retrospective analysis of clinical and laboratory factors associated with lymphoma in simian AIDS. Leuk Lymphoma (2004) 0.76
The surface glycoprotein of feline leukemia virus isolate FeLV-945 is a determinant of altered pathogenesis in the presence or absence of the unique viral long terminal repeat. J Virol (2013) 0.75
The surface glycoprotein of a natural feline leukemia virus subgroup A variant, FeLV-945, as a determinant of disease outcome. Vet Immunol Immunopathol (2011) 0.75
A thank you from Tulane University. Science (2007) 0.75